Lin CY - Search Results

1

Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3).

Okada M, Kato K, Cho BC, Takahashi M, Lin CY, Chin K, Kadowaki S, Ahn MJ, Hamamoto Y, Doki Y, Yen CC, Kubota Y, Kim SB, Hsu CH, Holtved E, Xynos I, Matsumura Y, Takazawa A, Kitagawa Y. Okada M, et al. Among authors: lin cy. Clin Cancer Res. 2022 Aug 2;28(15):3277-3286. doi: 10.1158/1078-0432.CCR-21-0985. Clin Cancer Res. 2022. PMID: 35294546 Free PMC article.

2

Pretreatment metabolic tumor volumes to predict the short-term outcome of unresectable locally advanced squamous cell carcinoma of the esophagus treated with definitive chemoradiotherapy.

Chen SW, Hsieh TC, Ding HJ, Yen KY, Lin CY, Liang JA, Kao CH. Chen SW, et al. Among authors: lin cy. Nucl Med Commun. 2014 Mar;35(3):291-7. doi: 10.1097/MNM.0000000000000046. Nucl Med Commun. 2014. PMID: 24276528

3

Cost-effectiveness of neoadjuvant concurrent chemoradiotherapy versus esophagectomy for locally advanced esophageal squamous cell carcinoma: A population-based matched case-control study.

Lin CY, Fang HY, Feng CL, Li CC, Chien CR. Lin CY, et al. Thorac Cancer. 2016 Apr 26;7(3):288-95. doi: 10.1111/1759-7714.12326. Epub 2015 Dec 23. Thorac Cancer. 2016. PMID: 27148413 Free PMC article.

4

Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose.

Li CC, Fang HY, Lin CY, Shen WC, Chien CR. Li CC, et al. Among authors: lin cy. Anticancer Res. 2019 Jan;39(1):511-517. doi: 10.21873/anticanres.13142. Anticancer Res. 2019. PMID: 30591503

5

Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.

Guo JC, Lin CC, Lin CY, Hsieh MS, Kuo HY, Lien MY, Shao YY, Huang TC, Hsu CH. Guo JC, et al. Among authors: lin cy, lin cc. Anticancer Res. 2019 Oct;39(10):5675-5682. doi: 10.21873/anticanres.13765. Anticancer Res. 2019. PMID: 31570466

6

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.

Kato K, Cho BC, Takahashi M, Okada M, Lin CY, Chin K, Kadowaki S, Ahn MJ, Hamamoto Y, Doki Y, Yen CC, Kubota Y, Kim SB, Hsu CH, Holtved E, Xynos I, Kodani M, Kitagawa Y. Kato K, et al. Among authors: lin cy. Lancet Oncol. 2019 Nov;20(11):1506-1517. doi: 10.1016/S1470-2045(19)30626-6. Epub 2019 Sep 30. Lancet Oncol. 2019. PMID: 31582355 Clinical Trial.

7

Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiation.

Lin CY, Fang HY, Lein MY, Lin CC, Bai LY, Tsai MH, Chen CC, Hsieh TC, Wang YC, Liang JA, Li CC, Chien CR. Lin CY, et al. Among authors: lin cc. Anticancer Res. 2020 Apr;40(4):2387-2392. doi: 10.21873/anticanres.14208. Anticancer Res. 2020. PMID: 32234942

8

Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study.

Hsieh CY, Lein MY, Yang SN, Wang YC, Lin YJ, Lin CY, Hua CH, Tsai MH, Lin CC. Hsieh CY, et al. Among authors: lin cy, lin yj, lin cc. BMC Cancer. 2020 Sep 1;20(1):832. doi: 10.1186/s12885-020-07347-6. BMC Cancer. 2020. PMID: 32873270 Free PMC article. Clinical Trial.

9

Resveratrol-mediated ADAM9 degradation decreases cancer progression and provides synergistic effects in combination with chemotherapy.

Lin YS, Hsieh CY, Kuo TT, Lin CC, Lin CY, Sher YP. Lin YS, et al. Among authors: lin cy, lin cc. Am J Cancer Res. 2020 Nov 1;10(11):3828-3837. eCollection 2020. Am J Cancer Res. 2020. PMID: 33294270 Free PMC article.

10

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.

Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M; CheckMate 577 Investigators. Kelly RJ, et al. N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125. N Engl J Med. 2021. PMID: 33789008 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,737 results

Search Page

Filters